CERELA   05438
CENTRO DE REFERENCIA PARA LACTOBACILOS
Unidad Ejecutora - UE
congresos y reuniones científicas
Título:
Effect of probiotics on the microbiota and the production of cytokines at the intestinal level using an experimental model of obesity in balb/c mice
Autor/es:
NOVOTNY NÚÑEZ, IVANNA; DE MORENO DE LEBLANC, ALEJANDRA; MALDONADO GALDEANO, CAROLINA; PERDIGÓN GABRIELA
Lugar:
Buenos Aires
Reunión:
Congreso; Reunión Científica de la Sociedad Argentina de Inmunología (SAI) 1º Congreso Franco Argentino de Inmunología; 2010
Institución organizadora:
Sociedad Argentina de Inmunología
Resumen:
<!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;
mso-font-charset:0;
mso-generic-font-family:roman;
mso-font-pitch:variable;
mso-font-signature:-1610611985 1107304683 0 0 415 0;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;
mso-font-charset:0;
mso-generic-font-family:swiss;
mso-font-pitch:variable;
mso-font-signature:-520092929 1073786111 9 0 415 0;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{mso-style-unhide:no;
mso-style-qformat:yes;
mso-style-parent:"";
margin-top:0cm;
margin-right:0cm;
margin-bottom:10.0pt;
margin-left:0cm;
line-height:115%;
mso-pagination:widow-orphan;
font-size:11.0pt;
font-family:"Calibri","sans-serif";
mso-fareast-font-family:Calibri;
mso-bidi-font-family:"Times New Roman";
mso-fareast-language:EN-US;}
span.mediumtext
{mso-style-name:medium_text;
mso-style-unhide:no;}
span.shorttext
{mso-style-name:short_text;
mso-style-unhide:no;}
.MsoChpDefault
{mso-style-type:export-only;
mso-default-props:yes;
font-size:10.0pt;
mso-ansi-font-size:10.0pt;
mso-bidi-font-size:10.0pt;
mso-ascii-font-family:Calibri;
mso-fareast-font-family:Calibri;
mso-hansi-font-family:Calibri;}
@page Section1
{size:612.0pt 792.0pt;
margin:70.85pt 3.0cm 70.85pt 3.0cm;
mso-header-margin:36.0pt;
mso-footer-margin:36.0pt;
mso-paper-source:0;}
div.Section1
{page:Section1;}
-->
Obesity is a chronic disease, multifactorial,
characterized by excessive accumulation of body fat, adipose tissue hypertrophy
and alterations of the immune system. Dietary
factors and intestinal bacteria play an important role in the increased
incidence of obesity. The aim of this work was to evaluate the effect of a probiotic
fermented milk (PFM) or the probiotic bacterium Lactobacillus casei CRL
431 in obese mice. Mice received conventional (G1) or high-fat (G2) diet
and were given milk (A), PFM (B), the bacterial suspension (C) or water (D) during 3 months. The samples were taken each month. Body weight, clinical
parameters (glucose, TG, LDL, HDL and
total cholesterol) in serum, intestinal microbiota, the release of IFN-γ, IL-10
and IL-6 in intestinal fluid and the histological alterations in liver were
evaluated. We observed decrease in body weights and in clinical parameters in G2B
and G2C compared to G2A and G2D. IL-10 and IFN-γ were higher in G2D (1166±118)
and (475±153) respectively than in G1D (824±54) and (363±23) respectively at
the 1st month. After 3 months, IL-10 increased in G2B (1196±174) and
G2C (1367±118) compared to G2D and IFN-γ increased in G2B (565±30) compared to
the others groups. IL-6 increased in G2B after 2 months (575±0) and it was
maintained similar to G2C in the 3rd month, being higher than the
others groups (G2D:335±109 and G2A:231±188). These immune variations could be
related with changes in the intestinal microbiota. Significant increases of Bifidobcterium and Bacteroides were observed in G2B compared to G2A, G2C and G2D after
3 months of obesity. G2B also
decreased steatosis in the liver in relation the others groups. PFM
administration avoided the clinical and immunological side effects induced by
the high fat diet with increases of Bifidobacterium
and Bacteroides. The histological recovery
of the liver and stimulation the immune response at the intestinal levels was regulated
by the increases of IL-10.